News | February 22, 2023
Genomics, big data among key themes driving M&A activity in medical devices, says GlobalData
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
Agasta Software is engaged in research, development and commercialization of medical devices
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
With the recent sales force expansion and new product launches, we expect to be back to above-market growth
India formulation sales at Rs. 3,391.9 crore, up 7.1% over Q3 last year
The company is adding new capabilities of Combi-line for Microsphere, additional Bag line and lyos for the Penem block in Pashamylaram facility in Hyderabad and will be earmarking capital for further building on its Biosimilar CDMO facility
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
Merck intends to complete today the acquisition of Imago through a merger of Merck’s wholly owned subsidiary with and into Imago
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Subscribe To Our Newsletter & Stay Updated
